Pancreatic Cancer Research

ResearcherFudan UniversityActive in the last 2 years

Hengchao Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2977-8185; OpenAlex author ID A5101501143. Sources: OpenAlex.

Their work

Papers
15 (first author 4, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
43
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 3 papers · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers · 2024: 2 papers

Papers 15

  1. Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer. Co-author DOI 10.1186/s12967-024-05363-9↗
  2. Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth. Last author DOI 10.1186/s12967-024-05962-6↗
  3. hENT1's role in adjuvant intra-arterial gemcitabine-based chemotherapy for resectable pancreatic cancer patients. Co-author DOI 10.1186/s12876-023-02666-x↗
  4. PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. First author DOI 10.7150/ijbs.76756↗
  5. Rapid sample preparation workflow based on enzymatic nanoreactors for potential serum biomarker discovery in pancreatic cancer. Co-author DOI 10.1016/j.talanta.2021.123018↗
  6. CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14215434↗
  7. Reciprocal regulation of LOXL2 and HIF1α drives the Warburg effect to support pancreatic cancer aggressiveness. First author DOI 10.1038/s41419-021-04391-3↗
  8. WD repeat-containing protein 1 maintains β-Catenin activity to promote pancreatic cancer aggressiveness. Co-author DOI 10.1038/s41416-020-0929-0↗
  9. GFAT1/HBP/O-GlcNAcylation Axis Regulates β-Catenin Activity to Promote Pancreatic Cancer Aggressiveness. First author DOI 10.1155/2020/1921609↗
  10. Blood-based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Pancreatic Cancer and its Value to Guide Clinical Treatment. Co-author DOI 10.7150/jca.43087↗
  11. A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pancreatic Cancer. Co-author DOI 10.21873/cgp.20114↗
  12. Magnetic mesoporous nanospheres anchored with LyP-1 as an efficient pancreatic cancer probe. Co-author DOI 10.1016/j.biomaterials.2016.11.006↗
  13. Triple-functional albumin-based nanoparticles for combined chemotherapy and photodynamic therapy of pancreatic cancer with lymphatic metastases. Co-author DOI 10.2147/ijn.s131295↗
  14. An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line. Co-author DOI 10.2147/ijn.s93835↗
  15. Characterization of the role of the photosensitizer, deuteporfin, in the detection of lymphatic metastases in a pancreatic cancer xenograft model. First author DOI 10.3892/ol.2015.3441↗

Closest collaborators

The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Deliang Fu · 7 shared papers, 2017–2024 · strength 0.94
  2. Jichun Gu · 6 shared papers, 2017–2024 · strength 0.86
  3. Chen Jin · 6 shared papers, 2015–2024 · strength 0.73
  4. Rongkun Li · 3 shared papers, 2021–2024 · strength 0.51
  5. Shu‐Heng Jiang · 3 shared papers, 2020–2024 · strength 0.43
  6. Yishen Mao · 3 shared papers, 2019–2024 · strength 0.42
  7. Xinzhe Yu · 4 shared papers, 2015–2023 · strength 0.40
  8. Baian Tao · 2 shared papers, 2022–2024 · strength 0.36
  9. Pengyuan Yang · 3 shared papers, 2019–2022 · strength 0.35
  10. Ji Li · 2 shared papers, 2020–2024 · strength 0.31
  11. Deliang Fu · 3 shared papers, 2015–2020 · strength 0.30
  12. Xiaohui Liu · 2 shared papers, 2020–2022 · strength 0.26
  13. Yongjian Jiang · 3 shared papers, 2017–2020 · strength 0.25
  14. Yueting Xiong · 2 shared papers, 2019–2022 · strength 0.25
  15. Xi Xiao · 1 shared paper, 2024 · strength 0.23
  16. Di Yang · 3 shared papers, 2015–2020 · strength 0.22
  17. Xinyu Huang · 1 shared paper, 2023 · strength 0.22
  18. Wei Wang · 1 shared paper, 2023 · strength 0.22
  19. Siyu Zhou · 1 shared paper, 2024 · strength 0.21
  20. Hang He · 3 shared papers, 2015–2020 · strength 0.20
  21. Lie Yao · 2 shared papers, 2020 · strength 0.20
  22. Xi Pu · 1 shared paper, 2023 · strength 0.17
  23. Qian Ji · 1 shared paper, 2023 · strength 0.17
  24. Chongyi Jiang · 1 shared paper, 2023 · strength 0.17
  25. Chunzeng Jia · 1 shared paper, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.